Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Julphar
Fuji
McKinsey
US Army
Harvard Business School
UBS
Teva
Healthtrust
Cerilliant

Generated: August 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017794

« Back to Dashboard
NDA 017794 describes ATIVAN, which is a drug marketed by West-ward Pharms Int and Valeant Intl and is included in two NDAs. It is available from seven suppliers. Additional details are available on the ATIVAN profile page.

The generic ingredient in ATIVAN is lorazepam. There are eleven drug master file entries for this compound. Fifty-five suppliers are listed for this compound. Additional details are available on the lorazepam profile page.

Summary for NDA: 017794

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 017794

Ingredient-typeBenzodiazepines

Suppliers and Packaging for NDA: 017794

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ATIVAN
lorazepam
TABLET;ORAL 017794 NDA Valeant Pharmaceuticals North America LLC 0187-0063 0187-0063-01 100 TABLET in 1 BOTTLE (0187-0063-01)
ATIVAN
lorazepam
TABLET;ORAL 017794 NDA Valeant Pharmaceuticals North America LLC 0187-0063 0187-0063-10 1000 TABLET in 1 BOTTLE (0187-0063-10)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.5MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Boehringer Ingelheim
Deloitte
Cipla
Cantor Fitzgerald
US Army
UBS
Accenture
Johnson and Johnson
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot